Product Program year 2020 Source: CMS Open Payments

Qbw251

Drug

Open in the dashboard

General payments

$10,018

77 payments

Research payments

$2,785,352

81 payments

Through program year 2020, $10,018 in general payments and $2,785,352 in research payments were reported against Qbw251.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 Research $2,384,207 44
2019 General $10,018 77
2019 Research $401,145 37

Breakdown

Who paid General payments · program year 2019
  1. Novartis Pharmaceuticals Corporation $10,018 77 payments
Top recipients General payments · program year 2019
  1. Ricardo Tan Allergy · Los Angeles, CA $997 10% · 6 payments
  2. David Pham Pulmonary Disease · Westminster, CA $922 9% · 6 payments
  3. Edward Kerwin Allergy · Medford, OR $789 8% · 5 payments
  4. Robert Garver Pulmonary Disease · Andalusia, AL $766 8% · 7 payments
  5. Rachna Shah Allergy & Immunology · Melrose Park, IL $736 7% · 7 payments

The top 5 of 16 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pulmonary Disease Internal Medicine $3,664 39% · 6 practitioners
  2. Allergy Allergy & Immunology $1,787 19% · 2 practitioners
  3. Family Medicine $1,444 15% · 3 practitioners
  4. Allergy & Immunology $1,305 14% · 2 practitioners
  5. Internal Medicine $634 7% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $2,484 25% · 3 recipients
  2. North Carolina $908 9% · 2 recipients
  3. Texas $813 8% · 2 recipients
  4. Oregon $789 8% · 1 recipient
  5. Alabama $766 8% · 1 recipient

The top 5 of 12 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

77 general · 81 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record